C07K 14/49
Platelet-derived growth factor [pdgf]
Official title: Platelet-derived growth factor [PDGF]
C07K14/49 (Platelet-derived growth factor [pdgf]) appears on 173 US grants and 226 published applications in this corpus.
Search patents in C07K- Granted patents
- 173
- Published applications
- 226
- Assignees
- 153
- Inventors
- 553
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 6 | 0 |
| 1990 | 1 | 0 |
| 1991 | 4 | 0 |
| 1992 | 5 | 0 |
| 1993 | 5 | 0 |
| 1994 | 2 | 0 |
| 1995 | 5 | 0 |
| 1996 | 5 | 0 |
| 1997 | 6 | 0 |
| 1998 | 13 | 0 |
| 1999 | 11 | 0 |
| 2000 | 7 | 0 |
| 2001 | 4 | 0 |
| 2002 | 5 | 7 |
| 2003 | 1 | 19 |
| 2004 | 4 | 8 |
| 2005 | 4 | 12 |
| 2006 | 11 | 10 |
| 2007 | 2 | 10 |
| 2008 | 3 | 5 |
| 2009 | 3 | 9 |
| 2010 | 3 | 6 |
| 2011 | 4 | 8 |
| 2012 | 2 | 1 |
| 2013 | 0 | 5 |
| 2014 | 4 | 5 |
| 2015 | 5 | 6 |
| 2016 | 4 | 10 |
| 2017 | 4 | 11 |
| 2018 | 4 | 8 |
| 2019 | 4 | 16 |
| 2020 | 3 | 13 |
| 2021 | 8 | 11 |
| 2022 | 6 | 9 |
| 2023 | 3 | 16 |
| 2024 | 4 | 6 |
| 2025 | 2 | 10 |
| 2026 | 3 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Sheep PDGFD, nucleic acids encoding PDGFD and recombinant lentivirus, host cell and use thereof1 Sep 2026US 12,723,066 B2Institute of Biotechnology, Xinjiang Academy of Animal Science (China-Australia Sheep Research Centre, Xinjiang Academy of Animal Science)
- Engineering cell lines capable of proliferation in growth factor free media formulations24 Mar 2026US 12,584,109 B2Upside Foods, Inc.
- Combination grafts for tissue repair or regeneration applications10 Mar 2026US 12,569,593 B2Rejuvablast LLC
- Targeting anabolic drugs for accelerated fracture repair3 Jun 2025US 12,319,721 B2Purdue Research Foundation
- MSC-NTF specific exosomes and use thereof25 Feb 2025US 12,233,092 B2BrainStorm Cell Therapeutics Ltd.
- Engineered platelet-derived growth factor variants16 Jul 2026US 2026/0201004 A1Multus Biotechnology Limited
- Engineering cell lines capable of proliferation in growth factor free media formulations25 Jun 2026US 2026/0176588 A1Upside Foods, Inc.
- Novel platelet derived growth factor peptide mimetic26 Mar 2026US 2026/0085101 A1The University of Sydney
- Cell cultivation processes for preparing food products, products provided by said processes and a system for providing these processes19 Feb 2026US 2026/0049281 A1BTL Healthcare Technologies A.S.
- Targeting anabolic drugs for accelerated fracture repair8 Jan 2026US 2026/0008829 A1Purdue Research Foundation
Most cited
By later US patents
- Production of vascular endothelial cell growth factor406US 5,194,596 ACalifornia Biotechnology Inc. · 1993
- Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases229US 5,759,542 ANew England Deaconess Hospital Corporation · 1998
- DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF.sub.120 and hVEGF.sub.121140US 5,219,739 AScios Nova Inc. · 1993
- High affinity TGF.beta. nucleic acid ligands and inhibitors98US 6,124,449 ANeXstar Pharmaceuticals, Inc. · 2000
- Wound healing and bone regeneration using PDGF and IGF-I92US 4,861,757 AInstitute of Molecular Biology, Inc. · 1989